MYHEP D VIR contains two direct-acting antivirals: Sofosbuvir (NS5B polymerase inhibitor) and Daclatasvir (NS5A inhibitor). Together, they block HCV replication and reduce viral mutation risk.
Recommended for:
- Adults with confirmed chronic hepatitis C
- Genotype 1, 3, and other strains as advised
- Patients with compensated liver cirrhosis
- Treatment-naïve or previously treated individuals
- Use in combination with other antivirals (e.g. ribavirin) where necessary
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)